Process View
Any process that modulates the frequency, rate or extent of cell junction assembly.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of cell junction assembly"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.999 | Human | |
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.989 | Human | |
CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.970 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.946 | ||
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.928 | Human | |
VEGFA | vascular endothelial growth factor A | 0.896 | ||
PTK2 | PTK2 protein tyrosine kinase 2 | 0.889 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.785 | ||
RHOA | ras homolog gene family, member A | 0.692 | ||
MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.663 | ||
BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.622 | Human | |
NRP1 | neuropilin 1 | 0.615 | ||
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.602 | ||
S100A1 | S100 calcium binding protein A1 | 0.593 | Human | |
CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.582 | Human | |
S100B | S100 calcium binding protein B | 0.569 | Human | |
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.501 | Human | |
SMAD2 | SMAD family member 2 | 0.467 | ||
FYN | FYN oncogene related to SRC, FGR, YES | 0.428 | ||
EGFR | epidermal growth factor receptor | 0.360 | ||
PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.351 | Human | |
PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 0.347 | ||
CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.297 | ||
NCK2 | NCK adaptor protein 2 | 0.284 | ||
FKBP1A | FK506 binding protein 1A, 12kDa | 0.257 | ||
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.250 | ||
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.242 | ||
PTPRB | protein tyrosine phosphatase, receptor type, B | 0.241 | Human | |
ANGPT2 | angiopoietin 2 | 0.234 | ||
BMP2 | bone morphogenetic protein 2 | 0.230 | ||
SFN | stratifin | 0.225 | ||
EPHA2 | EPH receptor A2 | 0.217 | Human | |
RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.195 | ||
PRKAR1A | protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1) | 0.182 | ||
PTPN12 | protein tyrosine phosphatase, non-receptor type 12 | 0.180 | ||
ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.168 | ||
ENG | endoglin | 0.163 | ||
GAB1 | GRB2-associated binding protein 1 | 0.156 | ||
ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.143 | ||
CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.119 | ||
S100A6 | S100 calcium binding protein A6 | 0.111 | Human | |
CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.106 | ||
EFNA1 | ephrin-A1 | 0.104 | Human | |
ANXA2 | annexin A2 | 0.100 | ||
ZNF746 | zinc finger protein 746 | 0.097 | ||
RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 | 0.097 | ||
NCF1 | neutrophil cytosolic factor 1 | 0.093 | ||
NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.089 | Mouse | |
S100A9 | S100 calcium binding protein A9 | 0.088 | Human | |
PGF | placental growth factor | 0.081 | Human | |
PXN | paxillin | 0.080 | Human | |
ILK | integrin-linked kinase | 0.079 | ||
ANXA1 | annexin A1 | 0.076 | ||
EFNA5 | ephrin-A5 | 0.072 | ||
SMAD7 | SMAD family member 7 | 0.071 | ||
AREG | amphiregulin | 0.068 | ||
S100A8 | S100 calcium binding protein A8 | 0.067 | Human | |
RPS6KA2 | ribosomal protein S6 kinase, 90kDa, polypeptide 2 | 0.066 | ||
GDF5 | growth differentiation factor 5 | 0.065 | ||
APC | adenomatous polyposis coli | 0.065 | ||
DSP | desmoplakin | 0.064 | ||
PDGFA | platelet-derived growth factor alpha polypeptide | 0.064 | Human | |
PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.062 | ||
TGFB1 | transforming growth factor, beta 1 | 0.057 | ||
PLCG1 | phospholipase C, gamma 1 | 0.056 | ||
PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.055 | ||
ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.055 | ||
LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.051 | ||
S100A2 | S100 calcium binding protein A2 | 0.051 | Human | |
FKBP4 | FK506 binding protein 4, 59kDa | 0.050 | ||
GIPC1 | GIPC PDZ domain containing family, member 1 | 0.049 | ||
NCF2 | neutrophil cytosolic factor 2 | 0.047 | ||
BMPR1A | bone morphogenetic protein receptor, type IA | 0.046 | Human | |
EPHA7 | EPH receptor A7 | 0.046 | Human | |
AKIP1 | A kinase (PRKA) interacting protein 1 | 0.045 | ||
IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.045 | ||
TEK | TEK tyrosine kinase, endothelial | 0.045 | ||
TMSB10 | thymosin beta 10 | 0.044 | ||
GRB7 | growth factor receptor-bound protein 7 | 0.044 | ||
TGFB3 | transforming growth factor, beta 3 | 0.043 | ||
NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.043 | ||
ANGPT1 | angiopoietin 1 | 0.042 | ||
LIMK1 | LIM domain kinase 1 | 0.042 | ||
PDGFC | platelet derived growth factor C | 0.042 | ||
RUNDC3A | RUN domain containing 3A | 0.041 | ||
SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.039 | Rat | |
PRKG1 | protein kinase, cGMP-dependent, type I | 0.038 | ||
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.038 | ||
UBE2R2 | ubiquitin-conjugating enzyme E2R 2 | 0.037 | ||
S100A4 | S100 calcium binding protein A4 | 0.037 | Human | |
SYNJ1 | synaptojanin 1 | 0.036 | ||
TSC2 | tuberous sclerosis 2 | 0.036 | ||
RYR2 | ryanodine receptor 2 (cardiac) | 0.036 | ||
TRIP6 | thyroid hormone receptor interactor 6 | 0.036 | ||
TGFBR1 | transforming growth factor, beta receptor 1 | 0.036 | Human | |
DPYSL4 | dihydropyrimidinase-like 4 | 0.034 | ||
AKAP9 | A kinase (PRKA) anchor protein (yotiao) 9 | 0.034 | ||
ACVR1 | activin A receptor, type I | 0.032 | Human | |
SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.032 | ||
LMNA | lamin A/C | 0.031 | ||
PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.031 | ||
HOXA1 | homeobox A1 | 0.031 | ||
MARK3 | MAP/microtubule affinity-regulating kinase 3 | 0.031 | ||
ZYX | zyxin | 0.031 | ||
AGER | advanced glycosylation end product-specific receptor | 0.030 | ||
TNK2 | tyrosine kinase, non-receptor, 2 | 0.030 | ||
AKAP11 | A kinase (PRKA) anchor protein 11 | 0.030 | ||
MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.028 | ||
ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.028 | ||
RALGDS | ral guanine nucleotide dissociation stimulator | 0.028 | ||
BMP1 | bone morphogenetic protein 1 | 0.028 | ||
DPPA4 | developmental pluripotency associated 4 | 0.027 | ||
MSN | moesin | 0.027 | ||
LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.027 | ||
TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.027 | Human | |
RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.026 | ||
EZR | ezrin | 0.026 | ||
ARHGDIA | Rho GDP dissociation inhibitor (GDI) alpha | 0.026 | ||
RAP1A | RAP1A, member of RAS oncogene family | 0.025 | ||
SORBS3 | sorbin and SH3 domain containing 3 | 0.024 | ||
MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.024 | ||
NCL | nucleolin | 0.024 | ||
MAPK8 | mitogen-activated protein kinase 8 | 0.024 | ||
CDC42EP1 | CDC42 effector protein (Rho GTPase binding) 1 | 0.024 | ||
S100P | S100 calcium binding protein P | 0.024 | Human | |
FEM1B | fem-1 homolog b (C. elegans) | 0.023 | ||
CSK | c-src tyrosine kinase | 0.023 | ||
PRKCD | protein kinase C, delta | 0.022 | ||
CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.022 | ||
FAF1 | Fas (TNFRSF6) associated factor 1 | 0.022 | ||
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.022 | ||
PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.022 | ||
COL6A1 | collagen, type VI, alpha 1 | 0.021 | ||
ATXN1 | ataxin 1 | 0.021 | ||
PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.020 | ||
FURIN | furin (paired basic amino acid cleaving enzyme) | 0.020 | ||
PHF21A | PHD finger protein 21A | 0.020 | ||
ACVR1B | activin A receptor, type IB | 0.020 | Human | |
DIAPH1 | diaphanous homolog 1 (Drosophila) | 0.020 | ||
GHR | growth hormone receptor | 0.020 | ||
AHNAK | AHNAK nucleoprotein | 0.020 | ||
KRT8 | keratin 8 | 0.019 | ||
CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | 0.019 | ||
GAB2 | GRB2-associated binding protein 2 | 0.019 | ||
SCNN1B | sodium channel, nonvoltage-gated 1, beta | 0.019 | ||
USP15 | ubiquitin specific peptidase 15 | 0.019 | ||
FLT4 | fms-related tyrosine kinase 4 | 0.018 | Human | |
RPS6KA6 | ribosomal protein S6 kinase, 90kDa, polypeptide 6 | 0.017 | ||
MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.017 | ||
RYBP | RING1 and YY1 binding protein | 0.017 | ||
PRKAR2B | protein kinase, cAMP-dependent, regulatory, type II, beta | 0.017 | ||
MAP2K3 | mitogen-activated protein kinase kinase 3 | 0.017 | ||
BMP4 | bone morphogenetic protein 4 | 0.016 | ||
ATF7IP | activating transcription factor 7 interacting protein | 0.016 | ||
ASAP2 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 | 0.016 | ||
SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.016 | ||
KRT18 | keratin 18 | 0.016 | ||
MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.016 | Rat | |
S100A11 | S100 calcium binding protein A11 | 0.016 | Human | |
EPHA3 | EPH receptor A3 | 0.016 | ||
HSPG2 | heparan sulfate proteoglycan 2 | 0.016 | ||
NRP2 | neuropilin 2 | 0.016 | ||
LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.016 | ||
FN1 | fibronectin 1 | 0.016 | ||
MAP2 | microtubule-associated protein 2 | 0.015 | ||
PARVA | parvin, alpha | 0.015 | ||
PPP3CA | protein phosphatase 3, catalytic subunit, alpha isozyme | 0.015 | ||
LDLR | low density lipoprotein receptor | 0.015 | ||
PHLDA3 | pleckstrin homology-like domain, family A, member 3 | 0.015 | ||
VEGFC | vascular endothelial growth factor C | 0.015 | Human | |
RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 0.015 | ||
RHOG | ras homolog gene family, member G (rho G) | 0.014 | Human | |
TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.014 | ||
THBS1 | thrombospondin 1 | 0.014 | ||
CTTN | cortactin | 0.014 | ||
RHOC | ras homolog gene family, member C | 0.014 | ||
ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.014 | ||
FNDC3B | fibronectin type III domain containing 3B | 0.014 | ||
SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.014 | ||
PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.014 | ||
TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.013 | ||
SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.013 | ||
ITSN2 | intersectin 2 | 0.013 | ||
CNKSR1 | connector enhancer of kinase suppressor of Ras 1 | 0.013 | ||
SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.013 | ||
EMCN | endomucin | 0.013 | ||
JAG1 | jagged 1 | 0.013 | ||
PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.013 | ||
AKAP10 | A kinase (PRKA) anchor protein 10 | 0.013 | ||
ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.013 | ||
RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 0.013 | ||
S100A12 | S100 calcium binding protein A12 | 0.013 | Human | |
ZNF426 | zinc finger protein 426 | 0.012 | ||
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.012 | ||
SETD7 | SET domain containing (lysine methyltransferase) 7 | 0.012 | ||
WNK1 | WNK lysine deficient protein kinase 1 | 0.012 | ||
VCL | vinculin | 0.012 | ||
CD34 | CD34 molecule | 0.012 | ||
DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.012 | ||
HEY1 | hairy/enhancer-of-split related with YRPW motif 1 | 0.012 | ||
PLAU | plasminogen activator, urokinase | 0.012 | ||
TFRC | transferrin receptor (p90, CD71) | 0.012 | ||
SHB | Src homology 2 domain containing adaptor protein B | 0.012 | ||
MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.012 | ||
ATP8 | ATP synthase F0 subunit 8 | 0.012 | ||
PRKACB | protein kinase, cAMP-dependent, catalytic, beta | 0.012 | Human | |
CEACAM6 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | 0.012 | ||
LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.012 | ||
LRP1 | low density lipoprotein receptor-related protein 1 | 0.012 | ||
LAMB3 | laminin, beta 3 | 0.012 | ||
BCR | breakpoint cluster region | 0.012 | ||
PDE2A | phosphodiesterase 2A, cGMP-stimulated | 0.012 | ||
PI3 | peptidase inhibitor 3, skin-derived | 0.012 | ||
MYH9 | myosin, heavy chain 9, non-muscle | 0.012 | ||
SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.012 | ||
CTSB | cathepsin B | 0.011 | ||
ZMYND11 | zinc finger, MYND-type containing 11 | 0.011 | ||
ACVRL1 | activin A receptor type II-like 1 | 0.011 | ||
KIAA1539 | KIAA1539 | 0.011 | ||
DUSP7 | dual specificity phosphatase 7 | 0.011 | ||
RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.011 | ||
PSG5 | pregnancy specific beta-1-glycoprotein 5 | 0.011 | ||
BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 0.011 | ||
MCAM | melanoma cell adhesion molecule | 0.011 | ||
USP2 | ubiquitin specific peptidase 2 | 0.011 | ||
RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.011 | ||
HIPK3 | homeodomain interacting protein kinase 3 | 0.011 | ||
REPS2 | RALBP1 associated Eps domain containing 2 | 0.011 | ||
EPHB6 | EPH receptor B6 | 0.011 | Human | |
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.011 | ||
BGN | biglycan | 0.011 | ||
GPR116 | G protein-coupled receptor 116 | 0.011 | ||
EHD2 | EH-domain containing 2 | 0.011 | ||
RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.011 | ||
NOTCH4 | notch 4 | 0.011 | ||
EPAS1 | endothelial PAS domain protein 1 | 0.011 | ||
PDLIM4 | PDZ and LIM domain 4 | 0.011 | ||
ANTXR2 | anthrax toxin receptor 2 | 0.011 | ||
TRIM9 | tripartite motif containing 9 | 0.011 | ||
ANGPTL4 | angiopoietin-like 4 | 0.011 | ||
JUB | jub, ajuba homolog (Xenopus laevis) | 0.011 | ||
EFHD2 | EF-hand domain family, member D2 | 0.010 | ||
LUM | lumican | 0.010 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.010 | ||
GSK3B | glycogen synthase kinase 3 beta | 0.010 | ||
TGFB2 | transforming growth factor, beta 2 | 0.010 | ||
SLC16A3 | solute carrier family 16, member 3 (monocarboxylic acid transporter 4) | 0.010 | ||
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.010 | ||
EGR1 | early growth response 1 | 0.010 | ||
COL18A1 | collagen, type XVIII, alpha 1 | 0.010 | ||
SIK3 | SIK family kinase 3 | 0.010 | ||
IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.010 | ||
INHBA | inhibin, beta A | 0.010 | ||
LRSAM1 | leucine rich repeat and sterile alpha motif containing 1 | 0.010 | ||
MAPT | microtubule-associated protein tau | 0.010 | ||
CSTA | cystatin A (stefin A) | 0.010 | ||
PPP1R12A | protein phosphatase 1, regulatory (inhibitor) subunit 12A | 0.010 | ||
KLF5 | Kruppel-like factor 5 (intestinal) | 0.010 |